000 01186 a2200325 4500
005 20250517183734.0
008 ####s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.19085
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJoshi, Avadhut D
245 0 0 _aSynergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients.
_h[electronic resource]
260 _bOncotarget
_cOct 2017
300 _a80124-80138 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aBotham, Rachel C
700 1 _aSchlein, Lisa J
700 1 _aRoth, Howard S
700 1 _aMangraviti, Antonella
700 1 _aBorodovsky, Alexandra
700 1 _aTyler, Betty
700 1 _aJoslyn, Steve
700 1 _aLooper, Jayme S
700 1 _aPodell, Michael
700 1 _aFan, Timothy M
700 1 _aHergenrother, Paul J
700 1 _aRiggins, Gregory J
773 0 _tOncotarget
_gvol. 8
_gno. 46
_gp. 80124-80138
856 4 0 _uhttps://doi.org/10.18632/oncotarget.19085
_zAvailable from publisher's website
999 _c27764197
_d27764197